Naproxen and naproxen sodium in dysmenorrhea: development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy
- PMID: 380249
- DOI: 10.3109/00016347909157802
Naproxen and naproxen sodium in dysmenorrhea: development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy
Similar articles
-
The effect of inhibitors of prostaglandin synthesis in primary dysmenorrhea studied with hysterometry.Acta Obstet Gynecol Scand Suppl. 1979;87:45-49. doi: 10.3109/00016347909157789. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 380251 Clinical Trial.
-
Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative.Acta Obstet Gynecol Scand. 1978;57(5):421-8. doi: 10.3109/00016347809156523. Acta Obstet Gynecol Scand. 1978. PMID: 103358 Clinical Trial.
-
Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.Acta Obstet Gynecol Scand Suppl. 1979;87:51-6. doi: 10.3109/00016347909157790. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 111466
-
Current status of the etiology and management of dysmenorrhea in adolescence.Pediatrics. 1982 Oct;70(4):516-25. Pediatrics. 1982. PMID: 6812011 Review. No abstract available.
-
A rationale for the treatment of dysmenorrhea.J Reprod Med. 1980 Oct;25(4 Suppl):213-21. J Reprod Med. 1980. PMID: 7001020 Review.
Cited by
-
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.Cochrane Database Syst Rev. 2015 Jul 30;2015(7):CD001751. doi: 10.1002/14651858.CD001751.pub3. Cochrane Database Syst Rev. 2015. PMID: 26224322 Free PMC article.
-
Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.Drugs. 1981 Jul;22(1):42-56. doi: 10.2165/00003495-198122010-00003. Drugs. 1981. PMID: 6790261 Review.